Tag: FDA enforcement

OPDP: There Are “A Number of Things” Companies Can Do to Avoid Enforcement Actions

Sunshine Act Data Could Increase FDA’s Ability to Prosecute Marketing Violations

OPDP Discusses Latest Batch of Enforcement Letters, Addresses Hot Topics

Next OPDP Webinar Will Address Five Months of Enforcement Actions

White Paper Examines FDA Enforcement in Digital, Social Media Realm

OPDP Untitled Letters on PR Materials Surprise Industry

Eye on FDA Data Analysis Shows Videos Are Cited Most for Risk Minimization, Overstatement of Efficacy

OPDP Enforcement Webinar Slated for Oct. 29

OPDP Issues Seven Enforcement Letters in May and June